Roche Drug Helps Breast Cancer Patients in Advanced Trial

Roche Holding AG’s experimental drug giredestrant helped patients with a form of advanced breast cancer live longer without the disease worsening in an advanced trial.

Whether the medicine can prolong lives, a goal called overall survival, remains to be seen but Roche noted “a clear positive trend” in a statement Monday.